AUTISM SPEAKS | MedPath

LinusBio and Autism Speaks Join Forces to Accelerate Early Autism Diagnosis Through Hair Biomarker Test

2 months ago

• LinusBio and Autism Speaks have partnered to promote ClearStrand-ASD, a first-in-class biochemical test that identifies autism biomarkers in hair strands of infants and toddlers aged 1-36 months. • The collaboration will integrate the diagnostic tool with Autism Speaks' Autism Response Team and upcoming Empower Summit events, while providing educational resources and reduced-cost testing for families in need. • Early diagnosis is critical for autism intervention, with ClearStrand-ASD offering healthcare providers a new screening option for children at elevated risk, including those born preterm or with siblings on the autism spectrum.